Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Biolex Therapeutics
company
About
Biolex Therapeutics developed therapeutic proteins and monoclonal antibodies that had been optimized to enhance their efficacy and potency.
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $24.40M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 1997
- Number Of Employee
- 1 - 10
- Operating Status
- Close
Biolex is a clinical-stage biopharmaceutical company that uses their patented LEX SystemSM to develop hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance their efficacy and potency. The LEX System is a technology that genetically transforms the aquatic plant Lemna to enable the production of biologic product candidates. Their main product aims at treating those afflicted with Hepatitis C.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$24.40M
Biolex Therapeutics has raised a total of
$24.40M
in funding over 2 rounds. Their latest funding was raised on
Aug 21, 2003 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 21, 2003 | Series Unknown | $24.40M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Biolex Therapeutics is funded by 2 investors.
Academy Centennial Fund
and The Trelys Funds
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
The Trelys Funds
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
